BioNTech SE at JPMorgan NAPA Valley Forum (Virtual) Transcript
All right. Good morning, everyone, and actually, good afternoon to you, Ryan. My name is Cory Kasimov, one of the senior biotech analysts at JPMorgan. And welcome to day 3 of our 10th Annual Napa Valley Biotech Forum. It is my pleasure to be here today hosting this discussion with BioNTech, one of the companies that's hopefully going to be a key reason why we're all gathered together in the actual Napa Valley next year.
So we have here with us Ryan Richardson, the Chief Strategy Officer and Managing Director from BioNTech. So Ryan, thank you very much for being here.
Before we get started with questions, let me just remind everybody, that you're able to contribute to this conversation using that little blue button in the portal to ask a question, and we'll work those into our conversation as we go forward.
So Ryan, thanks again. I look forward to this discussion with you today.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
